Physician profile
Daniel Yeh
NPI 1255532990
$48,121.87
in general payments reported to CMS, 2019-2025
7 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Trauma Surgery providers received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $9,063 · 2022: $5,738 · 2023: $9,536 · 2024: $272 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $20K · Education: $11K · Travel and Lodging: $1,647 · Food and Beverage: $499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,342.25 |
| Education | $10,834.00 |
| Travel and Lodging | $1,646.53 |
| Food and Beverage | $499.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $23,012.43 | 2021-2025 | Gattex |
| Baxter Healthcare | $12,203.71 | 2025 | Ips - Nutrition |
| Intuitive Surgical, INC. | $6,980.73 | 2025 | |
| Eli Lilly and Company | $3,200.00 | 2022 | |
| Fresenius Kabi USA, LLC | $1,850.00 | 2022 | |
| Innovation Technologies INC | $875.00 | 2023 | Irrisept |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Yeh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.